HESTA injects $4.4m into Aussie biotech startupBY CHLOE WALKER | WEDNESDAY, 1 JUN 2022 12:46PMSydney-based Inventia Life Science has announced the super fund's direct investment as it develops, manufactures and distributes the RASTRUM 3D bioprinter. Related News |
Editor's Choice
Key advice executive leaves Aware Super
Aware Super has farewelled its group executive of advice.
ASIC calls out sloppy adviser data
ASIC is reprimanding AFS licensees (AFSL) for submitting inaccurate information about their financial advisers and will ramp up its enforcement from August.
BlackRock acquires Preqin in $4.8bn deal
BlackRock will acquire Preqin in a US$3.2 billion cash deal, a move it says will transform its private markets capabilities.
Australian Retirement Trust delivers 11.3% in FY24
Australian Retirement Trust (ART) returned 11.3% p.a. for its High Growth option for the 2024 financial year.
Products
Expert Feed
Featured Profile
![Shail Singh Shail Singh](https://media.financialstandard.com.au/prod/media/library/Contacts/yqmjchgb-0002_featured_profile.png)
Shail Singh
LEAD INVESTMENT AND ADVICE OMBUDSMAN
AUSTRALIAN FINANCIAL COMPLAINTS AUTHORITY
AUSTRALIAN FINANCIAL COMPLAINTS AUTHORITY
To be successful as Australian Financial Complaints Authority's (AFCA) lead ombudsman for investments and advice, one requires empathy, impartiality, and rationality. Shail Singh shares how he also uses legal and financial advice expertise to help consumers, small businesses, and member firms. Karren Vergara writes.